Araştırma Makalesi
BibTex RIS Kaynak Göster

Yıl 2024, Cilt: 45 Sayı: 1, 80 - 87, 28.03.2024

Aybüke Züleyha Kaya Derya Osmaniye Asaf Evrim Evren Leyla Yurttaş Şeref Demirayak

https://doi.org/10.17776/csj.1392037

Öz

Kaynakça

  • [1] M. Hou, H.C. Li, N. An, S.Y. Pang, W.G. Li, J. Tong, Synthesis, crystal structures and anticancer studies of Ni (Ⅱ), Co (Ⅲ) and Zn (Ⅱ) complexes based on 5-bromosalicylaldehyde- 2-(2-aminophenyl)benzimidazole Schiff base, J. Mol. Struct., 1294 (2023) 136500.
  • [2] The top 10 causes of death, (n.d.). https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed November 15, 2023).
  • [3] D. Nuha, A.E. Evren, Z.Ş. Çiyanci, H.E. Temel, G. Akalin Çiftçi, L. Yurttaş, Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity, Arch Pharm (Weinheim), 355 (2022).
  • [4] İ. Celik, G. Ayhan-Kılcıgil, B. Guven, Z. Kara, A.S. Gurkan-Alp, A. Karayel, A. Onay-Besikci, Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors, Eur. J. Med. Chem., 173 (2019) 240–249.
  • [5] A.E. Evren, L. Yurttaş, B. Eksellı, G. Akalın-Cıftcı, Novel Tri-substituted Thiazoles Bearing Piperazine Ring: Synthesis and Evaluation of their Anticancer Activity, Lett Drug Des Discov 16 (2019) 547–555. https://doi.org/10.2174/1570180815666180731122118. A. Sharma, V. Luxami, K. Paul, Purine-benzimidazole hybrids: Synthesis, single crystal determination and in vitro evaluation of antitumor activities, Eur. J. Med. Chem., 93 (2015) 414–422.
  • [6] G. Satija, B. Sharma, A. Madan, A. Iqubal, M. Shaquiquzzaman, M. Akhter, S. Parvez, M.A. Khan, M.M. Alam, Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets, J. Heterocycl Chem., 59 (2022) 22–66.
  • [7] R. Singla, K.B. Gupta, S. Upadhyay, M. Dhiman, V. Jaitak, Design, synthesis and biological evaluation of novel indole-benzimidazole hybrids targeting estrogen receptor alpha (ER-α), Eur. J. Med. Chem., 146 (2018) 206–219..
  • [8] T.S. Reddy, H. Kulhari, V.G. Reddy, V. Bansal, A. Kamal, R. Shukla, Design, synthesis and biological evaluation of 1,3-diphenyl-1 H -pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents, Eur. J. Med. Chem., 101 (2015) 790–805.
  • [9] M.L. Di Gioia, R. Cassano, P. Costanzo, N. Herrera Cano, L. Maiuolo, M. Nardi, F.P. Nicoletta, M. Oliverio, A. Procopio, Green Synthesis of Privileged Benzimidazole Scaffolds Using Active Deep Eutectic Solvent, Molecules, 24 (2019) 2885.
  • [10] K. Laxmikeshav, A. Himaja, N. Shankaraiah, Exploration of benzimidazoles as potential microtubule modulators: An insight in the synthetic and therapeutic evolution, J. Mol. Struct., 1253 (2022) 132251.
  • [11] N. Shrivastava, Mohd.J. Naim, Md.J. Alam, F. Nawaz, S. Ahmed, O. Alam, Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure–Activity Relationship, Arch Pharm (Weinheim), 350 (2017).
  • [12] Y.T. Lee, Y.J. Tan, C.E. Oon, Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine, Acta. Pharm. Sin. B, 13 (2023) 478–497.
  • [13] W. Hou, W. Dai, H. Huang, S.-L. Liu, J. Liu, L.-J. Huang, X.-H. Huang, J.-L. Zeng, Z.-W. Gan, Z.-Y. Zhang, J.-X. Lan, Pharmacological activity and mechanism of pyrazines, Eur. J. Med. Chem., 258 (2023) 115544.
  • [14] Ş. Demirayak, L. Yurttaş, Synthesis and anticancer activity of some 1,2,3-trisubstituted pyrazinobenzimidazole derivatives, J. Enzyme Inhib. Med. Chem., 29 (2014) 811–822.
  • [15] W.R. Siegart, A.R. Day, Metabolite Analogs. VII. Preparation of Some Benzimidazolyl Analogs of Ethyl Pteroylglutamate, J. Am. Chem. Soc., 79 (1957) 4391–4394..
  • [16] G. Cheeseman, 2-ACETYLBENZIMIDAZOLE, J. Chem. Soc., (1964).
  • [17] S. Demirayak, K. Güven, Synthesis of some pyrido- and pyrazino-benzimidazole derivatives and their antifungal activity., Pharmazie, 50 (1995) 527–9.
  • [18] Demirayak S, Abu Mohsen U., Anticancer and anti-HIV activities of some pyrido/pyrazino-benzimidazole derivatives, Acta Pharm. Turc., 40 (1998) 9–12.
  • [19] M. V. Berridge, P.M. Herst, A.S. Tan, Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction, (2005) 127–152.
  • [20] D. Osmaniye, S. Levent, C.M. Ardıç, Ö. Atlı, Y. Özkay, Z.A. Kaplancıklı, Synthesis and anticancer activity of some novel benzothiazole-thiazolidine derivatives, Phosphorus Sulfur Silicon Relat. Elem., 193 (2018) 249–256.
  • [21] D. Osmaniye, B. Korkut Çelikateş, B.N. Sağlık, S. Levent, U. Acar Çevik, B. Kaya Çavuşoğlu, S. Ilgın, Y. Özkay, Z.A. Kaplancıklı, Synthesis of some new benzoxazole derivatives and investigation of their anticancer activities, Eur. J. Med. Chem., 210 (2021) 112979.
  • [22] D. Osmaniye, S. Levent, A. Karaduman, S. Ilgın, Y. Özkay, Z. Kaplancıklı, Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents, Molecules, 23 (2018) 1054.
  • [23] A.E. Evren, D. Nuha, L. Yurttaş, Focusing on the moderately active compound (MAC) in the design and development of strategies to optimize the apoptotic effect by molecular mechanics techniques, European Journal of Life Sciences, 1 (2023) 118–126.
  • [24] Protein Data Bank, (n.d.).
  • [25] Schrödinger Release. 2020-3, Maestro. Schrödinger, LLC, New York, NY, USA; 2020., (n.d.).
  • [26] LigPrep module, Schrödinger Release. 2020-3, Maestro. Schrödinger, LLC, New York, NY, USA; 2020., (n.d.).
  • [27] A.E. EVREN, S. DAWBAA, D. NUHA, Ş.A. YAVUZ, Ü.D. GÜL, L. YURTTAŞ, Design and synthesis of new 4-methylthiazole derivatives: In vitro and in silico studies of antimicrobial activity, J. Mol. Struct., 1241 (2021) 130692.
  • [28] Glide module, Schrödinger Release 2020-3, Glide, Schrödinger, LLC, New York, NY, USA (2020), (n.d.).

Synthesis, Cytotoxic Activity Evaluation and Molecular Docking Studies of Some Benzimidazole Derivatives

Yıl 2024, Cilt: 45 Sayı: 1, 80 - 87, 28.03.2024

Aybüke Züleyha Kaya Derya Osmaniye Asaf Evrim Evren Leyla Yurttaş Şeref Demirayak

https://doi.org/10.17776/csj.1392037

Öz

In this study, the synthesis of 2-(2-acetyl-1H-benzimidazol-1-yl)-1-arylethanone (3a-3d) and 1-methyl-3-phenyl-benzo[4,5]imidazo[1,2-a]pyrazine derivatives (4a-4d) and to investigate their cytotoxic activity were aimed. APCI, IR, 1HNMR, and 13CNMR spectra were utilized to determine the structure of the synthesized compounds. The cytotoxic activity of selected compounds were detected in A549 (human lung carcinoma) and NIH3T3 (mouse embryonic fibroblasts) cell lines. Compounds 4c and 4d were found to be selectively cytotoxic against A549 and NIH3T3 cell lines. Molecular docking studies were performed using the data retrieved from the Protein Data Bank server (PDBID: 4QTX).

Anahtar Kelimeler

Benzimidazole Pyrazinobenzimidazole Anticancer Molecular docking

Teşekkür

Our authors express their gratitude to the Herbal, Pharmaceutical, and Scientific Research Application and Research Center (AUBİBAM).

Kaynakça

  • [1] M. Hou, H.C. Li, N. An, S.Y. Pang, W.G. Li, J. Tong, Synthesis, crystal structures and anticancer studies of Ni (Ⅱ), Co (Ⅲ) and Zn (Ⅱ) complexes based on 5-bromosalicylaldehyde- 2-(2-aminophenyl)benzimidazole Schiff base, J. Mol. Struct., 1294 (2023) 136500.
  • [2] The top 10 causes of death, (n.d.). https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed November 15, 2023).
  • [3] D. Nuha, A.E. Evren, Z.Ş. Çiyanci, H.E. Temel, G. Akalin Çiftçi, L. Yurttaş, Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity, Arch Pharm (Weinheim), 355 (2022).
  • [4] İ. Celik, G. Ayhan-Kılcıgil, B. Guven, Z. Kara, A.S. Gurkan-Alp, A. Karayel, A. Onay-Besikci, Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors, Eur. J. Med. Chem., 173 (2019) 240–249.
  • [5] A.E. Evren, L. Yurttaş, B. Eksellı, G. Akalın-Cıftcı, Novel Tri-substituted Thiazoles Bearing Piperazine Ring: Synthesis and Evaluation of their Anticancer Activity, Lett Drug Des Discov 16 (2019) 547–555. https://doi.org/10.2174/1570180815666180731122118. A. Sharma, V. Luxami, K. Paul, Purine-benzimidazole hybrids: Synthesis, single crystal determination and in vitro evaluation of antitumor activities, Eur. J. Med. Chem., 93 (2015) 414–422.
  • [6] G. Satija, B. Sharma, A. Madan, A. Iqubal, M. Shaquiquzzaman, M. Akhter, S. Parvez, M.A. Khan, M.M. Alam, Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets, J. Heterocycl Chem., 59 (2022) 22–66.
  • [7] R. Singla, K.B. Gupta, S. Upadhyay, M. Dhiman, V. Jaitak, Design, synthesis and biological evaluation of novel indole-benzimidazole hybrids targeting estrogen receptor alpha (ER-α), Eur. J. Med. Chem., 146 (2018) 206–219..
  • [8] T.S. Reddy, H. Kulhari, V.G. Reddy, V. Bansal, A. Kamal, R. Shukla, Design, synthesis and biological evaluation of 1,3-diphenyl-1 H -pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents, Eur. J. Med. Chem., 101 (2015) 790–805.
  • [9] M.L. Di Gioia, R. Cassano, P. Costanzo, N. Herrera Cano, L. Maiuolo, M. Nardi, F.P. Nicoletta, M. Oliverio, A. Procopio, Green Synthesis of Privileged Benzimidazole Scaffolds Using Active Deep Eutectic Solvent, Molecules, 24 (2019) 2885.
  • [10] K. Laxmikeshav, A. Himaja, N. Shankaraiah, Exploration of benzimidazoles as potential microtubule modulators: An insight in the synthetic and therapeutic evolution, J. Mol. Struct., 1253 (2022) 132251.
  • [11] N. Shrivastava, Mohd.J. Naim, Md.J. Alam, F. Nawaz, S. Ahmed, O. Alam, Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure–Activity Relationship, Arch Pharm (Weinheim), 350 (2017).
  • [12] Y.T. Lee, Y.J. Tan, C.E. Oon, Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine, Acta. Pharm. Sin. B, 13 (2023) 478–497.
  • [13] W. Hou, W. Dai, H. Huang, S.-L. Liu, J. Liu, L.-J. Huang, X.-H. Huang, J.-L. Zeng, Z.-W. Gan, Z.-Y. Zhang, J.-X. Lan, Pharmacological activity and mechanism of pyrazines, Eur. J. Med. Chem., 258 (2023) 115544.
  • [14] Ş. Demirayak, L. Yurttaş, Synthesis and anticancer activity of some 1,2,3-trisubstituted pyrazinobenzimidazole derivatives, J. Enzyme Inhib. Med. Chem., 29 (2014) 811–822.
  • [15] W.R. Siegart, A.R. Day, Metabolite Analogs. VII. Preparation of Some Benzimidazolyl Analogs of Ethyl Pteroylglutamate, J. Am. Chem. Soc., 79 (1957) 4391–4394..
  • [16] G. Cheeseman, 2-ACETYLBENZIMIDAZOLE, J. Chem. Soc., (1964).
  • [17] S. Demirayak, K. Güven, Synthesis of some pyrido- and pyrazino-benzimidazole derivatives and their antifungal activity., Pharmazie, 50 (1995) 527–9.
  • [18] Demirayak S, Abu Mohsen U., Anticancer and anti-HIV activities of some pyrido/pyrazino-benzimidazole derivatives, Acta Pharm. Turc., 40 (1998) 9–12.
  • [19] M. V. Berridge, P.M. Herst, A.S. Tan, Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction, (2005) 127–152.
  • [20] D. Osmaniye, S. Levent, C.M. Ardıç, Ö. Atlı, Y. Özkay, Z.A. Kaplancıklı, Synthesis and anticancer activity of some novel benzothiazole-thiazolidine derivatives, Phosphorus Sulfur Silicon Relat. Elem., 193 (2018) 249–256.
  • [21] D. Osmaniye, B. Korkut Çelikateş, B.N. Sağlık, S. Levent, U. Acar Çevik, B. Kaya Çavuşoğlu, S. Ilgın, Y. Özkay, Z.A. Kaplancıklı, Synthesis of some new benzoxazole derivatives and investigation of their anticancer activities, Eur. J. Med. Chem., 210 (2021) 112979.
  • [22] D. Osmaniye, S. Levent, A. Karaduman, S. Ilgın, Y. Özkay, Z. Kaplancıklı, Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents, Molecules, 23 (2018) 1054.
  • [23] A.E. Evren, D. Nuha, L. Yurttaş, Focusing on the moderately active compound (MAC) in the design and development of strategies to optimize the apoptotic effect by molecular mechanics techniques, European Journal of Life Sciences, 1 (2023) 118–126.
  • [24] Protein Data Bank, (n.d.).
  • [25] Schrödinger Release. 2020-3, Maestro. Schrödinger, LLC, New York, NY, USA; 2020., (n.d.).
  • [26] LigPrep module, Schrödinger Release. 2020-3, Maestro. Schrödinger, LLC, New York, NY, USA; 2020., (n.d.).
  • [27] A.E. EVREN, S. DAWBAA, D. NUHA, Ş.A. YAVUZ, Ü.D. GÜL, L. YURTTAŞ, Design and synthesis of new 4-methylthiazole derivatives: In vitro and in silico studies of antimicrobial activity, J. Mol. Struct., 1241 (2021) 130692.
  • [28] Glide module, Schrödinger Release 2020-3, Glide, Schrödinger, LLC, New York, NY, USA (2020), (n.d.).
Toplam 28 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Farmasotik Kimya
Bölüm Natural Sciences
Yazarlar

Aybüke Züleyha Kaya 0009-0002-1614-2380

Derya Osmaniye 0000-0002-0499-436X

Asaf Evrim Evren 0000-0002-8651-826X

Leyla Yurttaş 0000-0002-0957-6044

Şeref Demirayak 0000-0002-0841-1299

Yayımlanma Tarihi 28 Mart 2024
Gönderilme Tarihi 16 Kasım 2023
Kabul Tarihi 12 Mart 2024
Yayımlandığı Sayı Yıl 2024Cilt: 45 Sayı: 1

Kaynak Göster

APA Kaya, A. Z., Osmaniye, D., Evren, A. E., Yurttaş, L., vd. (2024). Synthesis, Cytotoxic Activity Evaluation and Molecular Docking Studies of Some Benzimidazole Derivatives. Cumhuriyet Science Journal, 45(1), 80-87. https://doi.org/10.17776/csj.1392037
 Kapak Resmi İndir